Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Chinese Patent Office
Deloitte
Novartis
Healthtrust
Accenture
Argus Health
Fish and Richardson
Covington
Farmers Insurance

Generated: October 20, 2017

DrugPatentWatch Database Preview

CHILDREN'S ADVIL Drug Profile

« Back to Dashboard

Which patents cover Children's Advil, and what generic Children's Advil alternatives are available?

Children's Advil is a drug marketed by Wyeth Cons and Pfizer and is included in five NDAs.

The generic ingredient in CHILDREN'S ADVIL is ibuprofen; pseudoephedrine hydrochloride. There are sixty-four drug master file entries for this compound. Thirty-one suppliers are listed for this compound. Additional details are available on the ibuprofen; pseudoephedrine hydrochloride profile page.

Summary for Tradename: CHILDREN'S ADVIL

US Patents:0
Applicants:2
NDAs:5
Suppliers / Packagers: see list2
Bulk Api Vendors: see list109
Clinical Trials: see list6,544
Patent Applications: see list9,697
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:CHILDREN'S ADVIL at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Wyeth Cons
CHILDREN'S ADVIL
ibuprofen
SUSPENSION;ORAL019833-002Sep 19, 1989DISCNNoNo► Subscribe► Subscribe► Subscribe
Pfizer
CHILDREN'S ADVIL ALLERGY SINUS
chlorpheniramine maleate; ibuprofen; pseudoephedrine hydrochloride
SUSPENSION;ORAL021587-001Feb 24, 2004OTCYesYes► Subscribe► Subscribe► Subscribe
Pfizer
CHILDREN'S ADVIL
ibuprofen
TABLET, CHEWABLE;ORAL020944-001Dec 18, 1998OTCNoNo► Subscribe► Subscribe► Subscribe
Pfizer
CHILDREN'S ADVIL
ibuprofen
SUSPENSION;ORAL020589-001Jun 27, 1996OTCNoNo► Subscribe► Subscribe► Subscribe
Pfizer
CHILDREN'S ADVIL-FLAVORED
ibuprofen
SUSPENSION;ORAL020589-002Nov 7, 1997OTCNoNo► Subscribe► Subscribe► Subscribe
Pfizer
CHILDREN'S ADVIL COLD
ibuprofen; pseudoephedrine hydrochloride
SUSPENSION;ORAL021373-001Apr 18, 2002OTCNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: CHILDREN'S ADVIL

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Wyeth Cons
CHILDREN'S ADVIL
ibuprofen
SUSPENSION;ORAL019833-002Sep 19, 1989► Subscribe► Subscribe
Pfizer
CHILDREN'S ADVIL
ibuprofen
SUSPENSION;ORAL020589-001Jun 27, 1996► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Fish and Richardson
Fuji
McKesson
Healthtrust
Merck
Mallinckrodt
AstraZeneca
QuintilesIMS
Julphar
US Department of Justice

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot